Cord Blood News Volume 13.07 | Feb 25 2021

    0
    86







    2021-02-25 | CBN 12.07


    Cord Blood News by STEMCELL Technologies
    Vol. 12.06 – 25 February, 2021
    TOP STORY

    Development of an Optimized and Scalable Method for Isolation of Umbilical Cord Blood-Derived Small Extracellular Vesicles for Future Clinical Use

    Investigators describe an optimized and upscalable process for the isolation of extracellular vescicles smaller than 200nm, secreted by umbilical cord blood mononuclear cells under ischemic conditions and propose quality control thresholds for the isolated vesicles, based on the thorough characterization of their protein, lipid and RNA content.
    [Stem Cells Translational Medicine]

    Full Article
    Enter a contest to win a personalized lab coat by subscribing to Organoid News!
    PUBLICATIONSRanked by the impact factor of the journal

    Vitamin E Pretreated Wharton’s Jelly-Derived Mesenchymal Stem Cells Attenuate CCl4-Induced Hepatocyte Injury In Vitro and Liver Fibrosis In Vivo

    The authors used rat liver-derived hepatocytes injured by CCl4 treatment in co-culture system with Vitamin E pretreated-Wharton’s jelly-derived MSCs (WJMSCs) to evaluate the hepatoprotective effect of vitamin E-WJMSCs.
    [Biochemical Pharmacology]

    Full ArticleGraphical Abstract

    Human Mesenchymal Stem Cells Promote Ischemic Repairment and Angiogenesis of Diabetic Foot through Exosome miRNA-21-5p

    Exosomes were isolated from MSCs using ultracentrifugation, and further characterized by the nanoparticle tracking analyzer and flow cytometry. RNA sequencing, Western Blot, in vitro cell proliferation, in vivo pro-angiogenesis, as well as ischemic repairment of diabetic foot through rat model were performed to evaluate exosome physiological functions.
    [Stem Cell Research]

    Abstract

    Human Umbilical Cord Mesenchymal Stem Cells Attenuate Podocyte Injury under High Glucose via TLR2 and TLR4 Signaling

    Scientists investigated the effects of high glucose on the innate immunity of podocytes and diabetic nephropathy mice via Toll like receptor (TLR) signaling, and explored the protective effects of human umbilical cord-MSCs on this process.
    [Diabetes Research and Clinical Practice]

    Full Article

    Reduced Angiovasculogenic and Increased Inflammatory Profiles of Cord Blood Cells in Severe but Not Mild Preeclampsia

    To better understand the effects of preeclampsia on angio-vasculogenesis and inflammatory networks in the fetus and to identify their biological signatures, researchers investigated the quantitative and functional characteristics of cord blood-derived mononuclear cells (MNCs) and CD31-positive MNCs.
    [Scientific Reports]

    Full Article

    Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Ameliorate HaCaT Cell Photo-Aging

    Researchers isolated exosomes derived from umbilical cord MSCs grown in a 3D culture system and explored their ability to modulate the photo-aging of HaCaT keratinocytes.
    [Rejuvenation Research]

    Abstract

    MicroRNA-6785-5p-Loaded Human Umbilical Cord Mesenchymal Stem Cells-Derived Exosomes Suppress Angiogenesis and Metastasis in Gastric Cancer via INHBA

    MiR-6785-5p and inhibin subunit beta A (INHBA) expression in gastric cancer (GC) tissues and cells were determined. GC cells were transfected with the vectors that altered miR-6785-5p or INHBA expression.
    [Life Sciences]

    Abstract

    Therapeutic Effects of Wharton’s Jelly-Derived Mesenchymal Stromal Cells on Behaviors, EEG Changes and NGF-1 in Rat Model of the Parkinson’s Disease

    The effects of human Wharton’s jelly-derived MSCs on hyperalgesia, anxiety deficiency and Pallidal local electroencephalogram impairment, alone and combined with L-dopa, were examined in a rat model of Parkinson’s disease.
    [Journal of Chemical Neuroanatomy]

    Abstract

    Getting enough cord blood HSCs for transplantation isn't easy. But she's paving the way. Watch Suzan Imren's webinar.
    REVIEWS

    Challenges and Advances in Clinical Applications of Mesenchymal Stromal Cells

    Scientists discuss the major challenges of MSC therapies in clinical application, the factors impacting the diversity of MSCs, the potential approaches that modify MSC products with the highest therapeutic potential, and finally the usage of MSCs for COVID-19 pandemic disease.
    [Journal of Hematology & Oncology]

    Full Article
    INDUSTRY AND POLICY NEWS

    Positive Outcomes of First Children Treated with Remestemcel-L for Multisystem Inflammatory Syndrome (MIS-C) and Heart Failure Post-COVID-19

    Mesoblast Limited has treated the first two children with their MSC product candidate remestemcel-L for life-threatening multisystem inflammatory syndrome (MIS-C) associated with COVID-19.MIS-C, a potentially life-threatening inflammatory condition which involves multiple critical organs and their vasculature, is associated with prior rather than active COVID-19 infection.
    [Mesoblast, Ltd.]

    Press Release
    FEATURED EVENT

    The American Association for Cancer Research (AACR) Annual Meeting 2021: Week 2

    May 17 – 21, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Senior Scientist – Assay Development

    CyberCoders – San Diego, California, United States

    Postdoctoral Position – Hematopoietic Development

    Icahn School of Medicine at Mount Sinai – New York, New York, United States

    Research Associate – Hematopoietic System Development

    St. Jude Children’s Research Hospital – Memphis, Tennessee, United States

    Faculty Position – Department of Hematology

    St. Jude Children’s Research Hospital – Memphis, Tennessee, United States

    Postdoctoral Associate – Epigenetic Mechanisms Governing Hematopoietic Stem Cell Lineage Commitment

    The Jackson Laboratory – Bar Harbor, Maine, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cord Blood News Twitter